Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages 4607-4615

  Révész, Dóra ^a   Milaneschi, Yuri ^a   Verhoeven, Josine E ^a   Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CELL AGING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC MARKER; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TELOMERE; TELOMERE HOMEOSTASIS; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; LONGITUDINAL STUDY; MIDDLE AGED; NETHERLANDS; PATHOLOGY; TELOMERE SHORTENING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CELL AGING; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; TELOMERE SHORTENING; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84916623050     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1851     Document Type: Article

References (54)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
2. Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106:661-673.
3. Olovnikov AM. Telomeres, telomerase, and aging: Origin of the theory. Exp Gerontol. 1996;31:443-448.
4. Epel E. How "reversible" is telomeric aging? Cancer Prev Res (Phila). 2012;5:1163-1168.
5. Epel ES, Lin J, Wilhelm FH, et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006;31:277-287.
6. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393-395.
7. Müezzinler A, Zaineddin AK, Brenner H. A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev. 2013;12:509-519.
8. Sahin E, Colla S, Liesa M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359-6517.
9. Monickaraj F, Gokulakrishnan K, Prabu P, et al. Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes. Clin Biochem. 2012;45:1432-1438.
10. Zannolli R, Mohn A, Buoni S, et al. Telomere length and obesity. Acta Paediatr. 2008;97:952-954.
11. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366:662-664.
12. Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M. Mean leukocyte telomere length shortening and type 2 diabetes mellitus: A case-control study. Transl Res. 2010;155:166-169.
13. Buxton JL, Walters RG, Visvikis-Siest S, Meyre D, Froguel P, Blakemore AIF. Childhood obesity is associated with shorter leukocyte telomere length. J Clin Endocrinol Metab. 2011;96:1500-1505.
14. Nordfjall K, Eliasson M, Stegmayr B, Melander O, Nilsson P, Roos G. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring). 2008;16:2682-2689.
15. Aviv A, Valdes A, Gardner JP, Swaminathan R, Kimura M, Spector TD. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab. 2006;91:635-640.
16. Demissie S, Levy D, Benjamin EJ, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006;5:325-330.
17. Harte AL, da Silva NF, Miller MA, et al. Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus. Exp Diabetes Res. 2012;2012:895185.
18. Lee M, Martin H, Firpo MA, Demerath EW. Inverse association between adiposity and telomere length: The Fels Longitudinal Study. Am J Hum Biol. 2011;23:100-106.
19. Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis. 2008;198:347-353.
20. Strandberg TE, Saijonmaa O, Tilvis RS, et al. Association of telomere length in older men with mortality and midlife body mass index and smoking. J Gerontol A Biol Sci Med Sci. 2011;66:815-820.
21. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165:14-21.
22. Bekaert S, De Meyer T, Rietzschel ER, et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell. 2007;6:639-647.
23. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005;111:2171-2173.
24. Monickaraj F, Aravind S, Gokulakrishnan K, et al. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 2012;365:343-350.
25. Njajou OT, Cawthon RM, Blackburn EH, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2012;36:1176-1179.
26. Cui Y, Gao YT, Cai Q, et al. Associations of leukocyte telomere length with body anthropometric indices and weight change in Chinese women. Obesity (Silver Spring). 2013;21:2582-2588.
27. Kim S, Parks CG, DeRoo LA, et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev. 2009;18:816-820.
28. Penninx BW, Beekman AT, Smit JH, et al. The Netherlands Study of Depression and Anxiety (NESDA): Rationale, objectives and methods. Int J Methods Psychiatr Res. 2008;17:121-140.
29. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e4715.
30. Aviv A, Hunt SC, Lin J, Cao X, Kimura M, Blackburn E. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res. 2011;39:e1341.
31. Révész D, Verhoeven JE, Milaneschi Y, de Geus EJ, Wolkowitz OM, Penninx BW. Dysregulated physiological stress systems and accelerated cellular aging. Neurobiol Aging. 2014;35:1422-1430.
32. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36 (Suppl 1): S11-S66.
33. Packard CJ. Overview of fenofibrate. Eur Heart J. 1998;19 (Suppl A): A62-A65.
34. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: A meta-analysis. J Hypertens. 2004;22:435-445.
35. van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand. 2010;122:30-39.
36. Stuurgroep Multidisciplinaire Richtlijnontwikkeling. Stoornissen in het gebruik van alcohol: Richtlijn voor de diagnostiek en behandeling van patiënten met een stoornis in het gebruik van alcohol. GGZ: Utrecht, The Netherlands; 2009.
37. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-1395.
38. Verhoeven J, Révész D, Epel E, Lin J, Wolkowitz O, Penninx B. Major depressive disorder and accelerated cellular aging: Results from a large psychiatric cohort study. Mol Psychiatry. 2014;19:895-901.
39. Gardner M, Bann D, Wiley L, et al. Gender and telomere length: Systematic review and meta-analysis. Exp Gerontol. 2014;51:15-27.
40. Twisk JW. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol. 2004;19:769-776.
41. Ma D, Zhu W, Hu S, Yu X, Yang Y. Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients. J Endocrinol Invest. 2013;36:1032-1037.
42. Melka MG, Abrahamowicz M, Leonard GT, et al. Clustering of the metabolic syndrome components in adolescence: Role of visceral fat. PLoS One. 2013;8:e82368.
43. Licht C, de Geus E, Penninx B. Dysregulation of the autonomic nervous system predicts the development of the Metabolic Syndrome. J Clin Endocrinol Metab. 2013;98:2484-2493.
44. Bakker SJ, IJzerman RG, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity: The missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis. 2000;148:17-21.
45. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol. 2013;10:274-283.
46. Chiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS, Hodes RJ. Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A. 2010;107:10148-10153.
47. Calado RT, Dumitriu B. Telomere dynamics in mice and humans. Semin Hematol. 2013;50:165-174.
48. Lin J, Epel E, Cheon J, et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J Immunol Methods. 2010;352:71-80.
49. Daniali L, Benetos A, Susser E, et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun. 2013;4:159719.
50. Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013;14:1112-1120.
51. Garcia-Calzon S, Moleres A, Marcos A, et al. Telomere Length as a Biomarker for Adiposity Changes after a Multidisciplinary Intervention in Overweight/Obese Adolescents: The EVASYON Study. PLoS One. 2014;9:e89828.
52. Li Y, Tergaonkar V. Noncanonical functions of telomerase: Implications in telomerase-targeted cancer therapies. Cancer Res. 2014;74:1639-1644.
53. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31:9-18.
54. Wu XQ, Huang C, He X, et al. Feedback regulation of telomerase reverse transcriptase: New insight into the evolving field of telomerase in cancer. Cell Signal. 2013;25:2462-2468.